acne vulgaris
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients with acne vulgaris expressing from moderate to severe symptoms in guideline 2) Patients who gave their written informed consent
Exclusion criteria
Exclusion criteria: 1) Patients taking some drugs(oral,topical or injective agents)expected to be indicated for the treatment of acne within 4 weeks 2) Patients with hypersensitivity to any of the study drugs 3) Patients continuously receiving non-steroidal anti-inflammatory drugs 4) Women who are pregnant,might be pregnant or lactating 5) Patients who are considered unsuitable for this study by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decrease percentage of the number of inflammatory lesion. | — |
Secondary
| Measure | Time frame |
|---|---|
| -Change of the number of inflammatory lesion and comedone -Safety -Change in patient QOL(Skindex-16) | — |
Countries
Japan